Salze und Polymorphe einer Tetracyclinverbindung

European patent · EP2807926 · In force

Register entry

Publication number
EP2807926
Application number
EP14156670
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 26, 2009
Published
Dec 3, 2014
Granted
Oct 7, 2020
Protection ends at the latest
May 25, 2029
Next annual fee due
May 31, 2027
IPC classes
A01N 37/18 (2006.01)
C07C 237/26 (2006.01)
A61K 31/16 (2006.01)
Priority
US 128712 P 23.05.2008
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 20, 2026

    Agent’s address changed

    Representative
    Dr. Lusuardi AG, Kreuzbühlstrasse 8, 8008 Zürich → Dr. Lusuardi AG, Stockerstrasse 8, 8002 Zürich

    Published in Swissreg on 20.10.2026

  2. Jun 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.05.2026 → 31.05.2027

    Published in Swissreg on 01.06.2026

  3. Jun 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.05.2025 → 31.05.2026

    Published in Swissreg on 01.06.2025

  4. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  5. Jun 9, 2023

    Change

    Published in Swissreg on 09.06.2023

  6. Jan 7, 2021

    Agent entered

    Representative
    Dr. Lusuardi AG, Kreuzbühlstrasse 8, 8008 Zürich

    Published in Swissreg on 07.01.2021

  7. Oct 7, 2020

    Granted

    Published in Swissreg on 07.10.2020

Parties

Holder

Paratek Pharmaceuticals, Inc.

75 Kneeland Street, Boston, MA 02111, US

Agent

Dr. Lusuardi AG

Stockerstrasse 8, 8002 Zürich

Inventor

Cvestovich, Raymond

Jersey City New Jersey 07304, US

Warchol, Tadeusz

Northborough Massachusetts 01532, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.